Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. | Virus Res | 2023 | 37364815 | PubTator, text mining | PubMed |
| Species-specific protein-protein interactions govern the humanization of the 20S proteasome in yeast. | Genetics | 2023 | 37364278 | PubTator, text mining | PubMed |
| The Role of DNA Viruses in Human Cancer. | Cancer Inform | 2023 | 37363356 | PubTator, text mining | PubMed |
| Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma. | Aging (Albany NY) | 2023 | 37354211 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| Interplay between proteasome function and inflammatory responses in e-cig vapor condensate-challenged lung epithelial cells. | Arch Toxicol | 2023 | 37344694 | PubTator, text mining | PubMed |
| ISG20 stimulates anti-tumor immunity via a double-stranded RNA-induced interferon response in ovarian cancer. | Front Immunol | 2023 | 37342328 | PubTator, text mining | PubMed |
| Proteomic analysis to identification of hypoxia related markers in spinal tuberculosis: a study based on weighted gene co-expression network analysis and machine learning. | BMC Med Genomics | 2023 | 37340462 | PubTator, text mining | PubMed |
| The interaction between Epstein-Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities. | Clin Transl Immunology | 2023 | 37337612 | PubTator, text mining | PubMed |
| The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review. | Front Immunol | 2023 | 37334371 | PubTator, text mining | PubMed |
| Patients' well-being during the transition period after psychiatric hospitalization to school: insights from an intensive longitudinal assessment of patient-parent-teacher triads. | BMC Psychol | 2023 | 37328898 | PubTator, text mining | PubMed |
| Regulation of PKR-dependent RNA translation inhibition by TRIM21 upon virus infection or other stress. | PLoS Pathog | 2023 | 37327222 | PubTator, text mining | PubMed |
| Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading? | Curr Treat Options Oncol | 2023 | 37318724 | PubTator, text mining | PubMed |
| Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis. | Microorganisms | 2023 | 37317236 | PubTator, text mining | PubMed |
| Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity. | Front Immunol | 2023 | 37304266 | PubTator, text mining | PubMed |
| Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection. | PLoS Pathog | 2023 | 37289831 | PubTator, text mining | PubMed |
| Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing. | Front Immunol | 2023 | 37287976 | PubTator, text mining | PubMed |
| Insights into anti-tumor immunity via the polyomavirus shared across human Merkel cell carcinomas. | Front Immunol | 2023 | 37287968 | PubTator, text mining | PubMed |
| P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease. | Alzheimers Res Ther | 2023 | 37287063 | PubTator, text mining | PubMed |
| Dynamic models for musical rhythm perception and coordination. | Front Comput Neurosci | 2023 | 37265781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=18